Affiliation:
1. Department of Orthopedic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China
Abstract
Low back pain is the leading cause of disability worldwide. Intervertebral disc degeneration (IDD) is the primary clinical risk factor for low back pain and the pathological cause of disc herniation, spinal stenosis, and spinal deformity. A possible approach to improve the clinical practice of IDD-related diseases is to incorporate biomarkers in diagnosis, therapeutic intervention, and prognosis prediction. IDD pathology is still unclear. Regarding molecular mechanisms, cellular signaling pathways constitute a complex network of signaling pathways that coordinate cell survival, proliferation, differentiation, and metabolism. Recently, stem cells have shown great potential in clinical applications for IDD. In this review, the roles of multiple signaling pathways and related stem cell treatment in IDD are summarized and described. This review seeks to investigate the mechanisms and potential therapeutic effects of stem cells in IDD and identify new therapeutic treatments for IDD-related disorders.
Funder
Natural Science Foundation of China
Health Science and Technology Program of Zhejiang Province
Zhejiang Provincial Natural Science Foundation
Subject
General Biochemistry, Genetics and Molecular Biology,Medicine (miscellaneous)
Reference165 articles.
1. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: A systematic analysis for the Global Burden of Disease Study 2015;Vos;Lancet,2016
2. Low back pain: A major global challenge;Clark;Lancet,2018
3. Persistent radiculopathy after surgical treatment for lumbar disc herniation: Causes and treatment options;Rogerson;Int. Orthop.,2019
4. Cartilaginous endplate avulsion is associated with modic changes and endplate defects, and residual back and leg pain following lumbar discectomy;Feng;Osteoarthr. Cartil.,2021
5. A new immunometabolic perspective of intervertebral disc degeneration;Francisco;Nat. Rev. Rheumatol.,2022